By Benjamin Chiou
Date: Tuesday 22 Jul 2025
(Sharecast News) - French pharma giant Sanofi announced on Tuesday that it is to purchase London-based respiratory virus vaccine developer Vicebio for up to $1.6bn.
No recent information was found.
Currency | Euro |
Share Price | 85.09 |
Change Today | 0.27 |
% Change | 0.32 % |
52 Week High | 109.62 |
52 Week Low | 77.52 |
Volume | 102,589 |
Shares Issued | 1,256.00m |
Market Cap | 106,877m |
Beta | 0.79 |
Time | Volume / Share Price |
10:13 | 10 @ 85.09 |
10:13 | 23 @ 85.09 |
10:13 | 23 @ 85.09 |
10:13 | 12 @ 85.09 |
10:13 | 50 @ 85.09 |
You are here: research